(Q38242626)

31 August 2017

title

Respiratory infections in patients undergoing mechanical ventilation. (English)

1 reference

31 August 2017

main subject

mechanical ventilation

1 reference

1

1 reference

31 August 2017

Despoina Koulenti

3

0 references

author name string

Thiago Lisboa

series ordinal

2

1 reference

31 August 2017

publication date

20 August 2014

1 reference

The Lancet. Respiratory medicine

31 August 2017

published in

1 reference

31 August 2017

volume

2

1 reference

31 August 2017

issue

9

1 reference

31 August 2017

page(s)

764-774

1 reference

International study of the prevalence and outcomes of infection in intensive care units

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Does this patient have ventilator-associated pneumonia?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

What can we learn from international ventilator-associated pneumonia rates?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

When policy gets it right: variability in u.s. Hospitals' diagnosis of ventilator-associated pneumonia*.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Use of the clinical pulmonary infection score to guide therapy for ventilator-associated pneumonia risks antibiotic overexposure in patients with trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Ventilator-Associated Tracheobronchitis in a Mixed Surgical and Medical ICU Population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Intubated patients developing tracheobronchitis or pneumonia have distinctive complement system gene expression signatures in the pre-infection period: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Characterization of bacterial biofilms on tracheostomy tubes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Prevention of VAP: is zero rate possible?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Device-associated infection rates in adult intensive care units of Cuban university hospitals: International Nosocomial Infection Control Consortium (INICC) findings

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Device-associated infection rates, device use, length of stay, and mortality in intensive care units of 4 Chinese hospitals: International Nosocomial Control Consortium findings.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Device-associated nosocomial infection rates in intensive care units of Argentina.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

A care bundle approach for prevention of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients*.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated Patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

The epidemiology of ventilator-associated pneumonia in a network of community hospitals: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

A randomized trial of diagnostic techniques for ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents: findings of the International Nosocomial Infection Control Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Effect of Antibiotic Diversity on Ventilator-Associated Pneumonia Caused by ESKAPE Organisms

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Assessment of severity of ICU-acquired pneumonia and association with etiology.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia*

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Ventilator-Associated Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Questionable superiority of linezolid for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: watch where you step

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Acquisition of extensive drug-resistant Pseudomonas aeruginosa among hospitalized patients: risk factors and resistance mechanisms to carbapenems

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Candida colonization in ventilated ICU patients: no longer a bystander!

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Pseudomonas aeruginosa acquisition on an intensive care unit: relationship between antibiotic selective pressure and patients' environment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Pseudomonas aeruginosa virulence and therapy: evolving translational strategies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheostomy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

De-escalation therapy in ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Accuracy of clinical definitions of ventilator-associated pneumonia: comparison with autopsy findings.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Incidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

The search for diagnostic markers in sepsis: many miles yet to go.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Promising new assays and technologies for the diagnosis and management of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Gene expression profiles differentiate between sterile SIRS and early sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

The Ventilator-Associated Pneumonia PIRO Score

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Antibiotic stewardship in hospital-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Aerosolized antibiotics to treat ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Nebulized Ceftazidime and Amikacin in Ventilator-associated Pneumonia Caused byPseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970171-7

7 January 2021

10.1016/S2213-2600(14)70171-7

Identifiers

DOI

1 reference

31 August 2017

1 reference